<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="figure" id="fig04" orientation="portrait" position="float">
 <label>Fig. 4.</label>
 <caption>
  <p>PR2B sfRNA is packaged inside E protein-containing infectious particles and transmitted into new susceptible cells. (
   <italic>A</italic>) Quantification of sfRNA:gRNA ratios in supernatant of A549 cells at 24 hpi by qPCR. (
   <italic>B</italic>) Quantification of gRNA:sfRNA ratios in supernatant of A549 cells on knockdown of CD9, CD63, CD81, and CD151. NTC served as a reference point for assessment of significance. (
   <italic>C</italic>–
   <italic>E</italic>) Quantification of gRNA copy numbers (
   <italic>C</italic>), sfRNA copy numbers (
   <italic>D</italic>), and sfRNA:gRNA ratios (
   <italic>E</italic>) from 4G2 pull-down precipitate. LOD, limit of detection; ND, no detection. PR1 served as a reference point for assessment of significance. (
   <italic>F</italic>) Western blots of CD63 and 4G2 in pull-down precipitate. (
   <italic>G</italic>–
   <italic>I</italic>) Quantification of gRNA (
   <italic>G</italic>), sfRNA (
   <italic>H</italic>), and sfRNA:gRNA ratios (
   <italic>I</italic>) in A549 cells at 2 hpi, after XRN1 knockdown. (
   <italic>J</italic>) Western blots of phosphorylated IRF3, IRF3, and LAMP-1 at 6 hpi with MOIs of 1 and 10 of mock, PR1, and PR1NS53UTR and cotreatment of NITD008. (
   <italic>K</italic>) Level of infection with MOIs of 1 and 10 of mock, PR1, and PR1NS53UTR quantified by immunofluorescence assay. Data are presented as mean ± SD. *
   <italic>P</italic> &lt; 0.05; **
   <italic>P</italic> &lt; 0.01; ***
   <italic>P</italic> &lt; 0.001; ***
   <italic>P</italic> &lt; 0.0001, unpaired 
   <italic>t</italic> test. ns, not significant.
  </p>
 </caption>
 <graphic id="gra4" xlink:href="pnas.1919287117fig04" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
